What is the total value of India's pharmaceutical export to Germany?

India exported pharmaceuticals worth $929.2M to Germany across 7,031 verified shipments.

Which companies in Germany import pharmaceuticals from India?

1. SANOFI INDIA LIMITED — $164.3M. 2. BOEHRINGER INGELHEIM INDIA PRIVATE LIMITED — $135.7M. 3. ROCHE DIAGNOSTICS INDIA PRIVATE LIMITED — $104.5M. 251 buyers total.

What pharmaceutical products does India export most to Germany?

1. Insulin ($244.5M, 26.3%); 2. Empagliflozin ($118.5M, 12.8%); 3. Vitamin ($99.3M, 10.7%); 4. Linagliptin ($78.0M, 8.4%); 5. Immunoglobulin ($67.7M, 7.3%)

Why does Germany import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $929.2M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Germany?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Germany pharmaceutical trade?

$132.2K per consignment across 7,031 shipments.

How many Indian pharmaceutical companies export to Germany?

338 Indian companies. Largest: BOEHRINGER INGELHEIM INTERNATIONAL with $133.7M.

How can I find verified Indian pharmaceutical suppliers for Germany?

TransData Nexus covers 338 active exporters with shipment history and trade values at transdatanexus.com.

Germany to India Pharmaceutical Import (2026) — $929.2M, 338 Foreign Suppliers | TransData Nexus

Q: Who are the top Indian pharmaceutical exporters to Germany?

1. BOEHRINGER INGELHEIM INTERNATIONAL — $133.7M. 2. SANOFI-AVENTIS SINGAPORE PTE LTD — $110.1M. 3. ROCHE DIAGNOSTICS INTERNATIONAL LTD — $103.5M. Total: 338 suppliers.

Germany to India Pharmaceutical Import (2026) — $929.2M, 338 Foreign Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — Germany to India

#	Formulation	Value	Share
1	Insulin	$244.5M	26.3%
2	Empagliflozin	$118.5M	12.8%
3	Vitamin	$99.3M	10.7%
4	Linagliptin	$78.0M	8.4%
5	Immunoglobulin	$67.7M	7.3%
6	Rivaroxaban	$64.5M	6.9%
7	Apixaban	$34.0M	3.7%
8	Vaccine	$28.5M	3.1%
9	Cetuximab	$27.2M	2.9%
10	Telmisartan	$22.8M	2.5%
11	Trastuzumab	$21.5M	2.3%
12	Metformin	$15.6M	1.7%
13	Pyrantel	$13.0M	1.4%
14	Mycophenolate	$12.0M	1.3%
15	Sodium	$11.1M	1.2%

India imports 20+ pharmaceutical formulations from Germany with a combined trade value of $929.2M. Key products include Insulin ($244.5M), Empagliflozin ($118.5M), Vitamin ($99.3M), Linagliptin ($78.0M), Immunoglobulin ($67.7M). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 7,031 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — Germany to India Trade Routes

1Insulin$244.5M

2Empagliflozin$118.5M

3Vitamin$99.3M

4Linagliptin$78.0M

5Immunoglobulin$67.7M

6Rivaroxaban

Top Germany Suppliers to India

1Boehringer Ingelheim International

$133.7M

2Sanofi-aventis Singapore Pte Ltd

$110.1M

3Roche Diagnostics International Ltd

$103.5M

4Sanofi-aventis Singapore Pte Limited

$33.7M

5Pfizer Service Company Bv

$27.4M

Trade Statistics

Total Value$929.2M

Shipments7,031

Indian Exporters338

Germany Buyers251

Avg Shipment$132K

Products223

Other Import Origins

United States$2.7B China$767.5M Italy$471.9M France

Last updated: March 28, 2026

India–Germany Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade corridor between Germany and India has experienced significant growth over the past two decades. In 2000, Germany's pharmaceutical exports to India were valued at approximately $50 million. By 2024, this figure had surged to $929.2 million, reflecting a substantial increase in bilateral trade. This growth can be attributed to India's expanding healthcare sector, rising demand for quality medicines, and Germany's strong pharmaceutical manufacturing capabilities. Key milestones include the establishment of direct distribution channels and the recognition of German pharmaceutical standards by Indian regulatory authorities.

2Germany's Role in India's Pharma Imports

Germany holds a significant position in India's pharmaceutical import landscape. In 2024, Germany accounted for approximately 1.2% of India's total pharmaceutical imports, valued at $929.2 million. The primary categories imported from Germany include insulin, empagliflozin, vitamins, linagliptin, and immunoglobulin. These products are essential in treating various chronic conditions prevalent in India, such as diabetes and cardiovascular diseases. The high quality and efficacy of German pharmaceutical products make them a preferred choice among Indian healthcare providers.

3Recent Developments

Germany Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1CDSCO Registration Process

German pharmaceutical companies seeking to import products into India must navigate the CDSCO registration process. The process involves several key steps:

1. Online Application: Applicants must register on the CDSCO's online portal, providing details about the company and the products intended for import.

2. Document Submission: Essential documents include a Certificate of Pharmaceutical Product (COPP), Good Manufacturing Practice (GMP) certificate, and a free sale certificate from the country of origin.

3. Product Dossier: A comprehensive dossier containing product information, including composition, manufacturing process, and stability data, must be submitted.

4. Fee Payment: An application fee, as specified by CDSCO, is required to process the registration.

5. Review and Approval: CDSCO reviews the application and may conduct inspections to verify compliance with Indian standards.

The entire process can take several months, depending on the complexity of the product and the completeness of the application.

2GMP & Manufacturing Standards

India requires that foreign manufacturing sites adhere to Good Manufacturing Practice (GMP) standards as outlined by the World Health Organization (WHO). German manufacturers must provide a valid GMP certificate issued by the competent authority in Germany. CDSCO may conduct inspections to ensure compliance with these standards. Additionally, products must meet the quality specifications set by CDSCO, and any deviations may result in rejection of the import application.

3Import Documentation

To import pharmaceutical products into India, German companies must prepare the following documents:

Import License (Form 10): Issued by CDSCO, this license authorizes the import of specific pharmaceutical products.

Registration Certificate: Confirms that the product is registered with CDSCO and meets Indian regulatory standards.

No Objection Certificate (NOC): Obtained from the Ministry of Health and Family Welfare, indicating no objection to the import.

Test License: Allows for the testing of imported products to ensure they meet quality standards.

Customs Procedures: Compliance with Indian customs regulations, including payment of applicable duties and taxes, is mandatory.

Ensuring all documentation is accurate and complete is crucial to avoid delays in the import process.

TransData Nexus Research · Germany regulatory databasesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Germany identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 7,031 verified shipments from 338 Indian exporters to 251 Germany buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

338 Exporters

251 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

Germany to India Pharmaceutical Import

Top Pharmaceutical Formulations — Germany to India

Top Pharmaceutical Products — Germany to India Trade Routes

Top Germany Suppliers to India

Trade Statistics

Other Import Origins

India–Germany Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2Germany's Role in India's Pharma Imports

3Recent Developments

Top Indian Buyers from Germany

Product Routes

Full Dataset Access

Germany Regulatory Landscape for Indian Pharmaceutical Exports

1CDSCO Registration Process

2GMP & Manufacturing Standards

3Import Documentation

Product Categories & Therapeutic Trends — India to Germany

1Dominant Import Categories

2Innovation & Specialty Imports

3Import Demand Drivers

Trade Policy & Tariff Intelligence — India and Germany

1India's Import Tariff Structure

2Trade Agreements & Preferences

3IP, Patents & Price Control

Supply Chain & Logistics — India to Germany Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

3Indian Customs & Cold Chain

FAQ — India to Germany Pharmaceutical Trade